3D-Printed Bone: EPFL Researchers Develop Self-Mineralizing Biomaterial Mimicking Natural Bone Structure

Researchers at the École Polytechnique Fédérale de Lausanne (EPFL) have announced a significant milestone in regenerative medicine with the creation of a pioneering composite material. This innovation, which can be utilized through 3D printing or as an injectable ink, possesses the unique ability to mineralize under standard environmental conditions, gradually transforming into a robust, bone-like architecture. Published in February 2026, this research represents a major departure from conventional manufacturing techniques that rely on extreme heat, paving the way for more advanced bone tissue engineering.

The development was spearheaded at EPFL’s Soft Materials Laboratory (SMaL), under the guidance of Professor Esther Amstad. The laboratory is renowned for its focus on biomimetic strategies, specifically in the creation of microstructured polymer materials that are reinforced through regulated mineralization. The core of this specific innovation lies in the formulation of an injectable ink centered around hydroxyapatite (HA), which serves as the primary mineral constituent of natural human bone.

The chemical makeup of the ink is sophisticated, incorporating gelatin microparticles that are embedded with the enzyme alkaline phosphatase. When these printed structures are incubated in a specialized solution containing calcium and phosphate ions, the enzyme triggers a controlled crystallization process of the hydroxyapatite. This reaction leads to the progressive hardening of the printed scaffold, effectively mimicking the natural biological processes of bone formation.

Professor Amstad explained that the primary objective was to design a 3D-printable and injectable medium capable of producing scaffolds with mechanical attributes similar to trabecular bone. This type of spongy bone is typically found within the vertebrae and at the extremities of long bones, such as the femur. By replicating these specific properties, the researchers aim to provide a more compatible solution for internal structural support and medical grafting.

One of the most striking features of this composite structure is the rapid rate at which it gains strength. Within just a few days of the mineralization process, the material achieves mechanical stability comparable to that of natural trabecular bone, allowing for early weight-bearing potential. This efficiency addresses the significant limitations of traditional hydroxyapatite scaffold production, which often requires high energy consumption and prevents the inclusion of heat-sensitive bioactive components like enzymes that are necessary to stimulate bone growth.

To facilitate biological integration, the EPFL team ensured the material remained porous enough for cellular infiltration. They achieved this by adding enzyme-free gelatin microfragments to the ink mixture. During the incubation phase, these specific fragments dissolve, leaving behind a network of pores that allow cells to migrate into the structure. The researchers successfully calibrated the material to reach a porosity of approximately 50% by volume, which is considered the ideal threshold for cell colonization and the subsequent growth of new bone tissue.

The practical efficacy of the material was demonstrated through cellular experiments. Just 14 days after seeding the scaffolds with human stem cells, the researchers identified the presence of collagen and osteocalcin in the samples. These biomarkers indicate that the natural process of bone formation had been successfully initiated. This breakthrough is of fundamental importance to the field of regenerative medicine, as it harmonizes energy efficiency with high biocompatibility and the potential for large-scale production.

Furthermore, the ability to conduct mineralization at room temperature drastically reduces the carbon footprint and overall manufacturing costs associated with synthetic bone grafts. Because the enzymatic activity is preserved within the scaffold, the material can continue to mature even after the initial printing process, potentially adapting to the specific physiological conditions of an individual patient. Comparative tests have confirmed that these enzymatically activated scaffolds possess a compressive strength that rivals human spongy bone, outperforming materials created through traditional high-temperature methods.

While dense cortical bone provides rigidity, spongy trabecular bone is essential for load distribution within joints and the spinal column. The capacity to engineer a material that precisely replicates these characteristics is vital for accelerating the healing of fractures and improving bone reconstruction outcomes. By merging advanced material science with enzymatic catalysis, this technological solution is poised to redefine how medical professionals treat bone-related injuries and degenerative diseases.